The purpose of this indicator is to measure sustainable access to vaccines.

This indicator aims to measure access to vaccines, including the newly available or underutilized vaccines, at the national level. In the past decades all countries added numerous new and underutilized vaccines in their national immunization schedule and there are several vaccines under final stage of development to be introduced by 2030. For monitoring diseases control and impact of vaccines it is important to measure coverage from each vaccine in national immunization schedule and the system is already in place for all national programmes, however direct measurement for proportion of population covered with all vaccines in the programme is only feasible if the country has a well-functioning national nominal immunization registry.

Ministry of Health

Ministry of Health

Annual

Percentage (%)

WHO provides global vaccine and immunization recommendations for diseases that have an international public health impact. National programmes adapt the recommendations and develop national immunization schedules, based on local disease epidemiology and national health priorities. National immunization schedules and number of recommended vaccines vary between countries, with only DTP polio and measles containing vaccines being used in all countries.

•  Coverage of DTP containing vaccine (3rd dose): Percentage of surviving infants who received the 3 doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year.
•  Coverage of Measles containing vaccine (2nd dose): Percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.
•  Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the nationally recommended doses of pneumococcal conjugate vaccine in a given year.
•  Coverage of HPV vaccine (last dose in the schedule): Percentage of 15 years old girls received the recommended doses of HPV vaccine.

is by geographical location, i.e. regional and national and potentially sub-national estimates.

WHO and UNICEF jointly developed a methodology to estimate national immunization coverage form selected vaccines in 2000. The methodology has been refined and reviewed by expert committees over time. The methodology was published, and reference is available under the reference section. Estimates time series for WHO recommended vaccines produced and published annually since 2001. The methodology uses data reported by national authorities from countries administrative systems as well as data from immunization or multi indicator household surveys.

For monitoring diseases control and impact of vaccines in the population for given vaccine based on recommended age for administration. The primary vaccination series of most vaccines are administered in the first two years of life.

Given that HPV vaccine is relatively new and vaccination schedule varies from countries to country coverage estimate will be made for girls vaccinated by age 15 and at the moment data is limited to very few countries therefore reporting will start later.

All the metadata shown in this document was gathered from United Nation Statistics Division. The metadata was extracted from https://unstats.un.org/sdgs/metadata/.